The German vaccine company BioNTech said on Tuesday that it could produce a vaccine in six weeks to deal with the new coronavirus mutation.
According to foreign media, the CEO of BioNTech, Ugur Sahin, clarified that "so far we do not know if the vaccine protects us from the new strain of the virus, but if needed and not enough, then the German pharmaceutical company may have ready a vaccine in six weeks. "
Sahin, however, believes that the vaccine will be effective, but as he added "we will know in about two weeks from now when we receive the new data".
"The chance that our. Vaccine will work is relatively high," concluded the CEO of BioNTech.
The BioNTech vaccine, developed in partnership with US pharmaceutical company Pfizer, has been approved for use in more than 45 countries, including Britain, the United States and the EU.
Meanwhile, the World Health Organization is expected to convene a meeting of its members to discuss ways to address the new strain of the virus.
Meanwhile, a high-ranking official in Germany said that we are not yet able to have a sufficient picture of the new strain of the virus in Britain.
Source: KYPE